chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Throat irritation
Clinical narrative: Itchy throat/ itching inside throat area; Itching in the inside of ears; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 17:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease (years in remission). Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing. The patient previously received Propranolol, Augmentin, Keflux, Septra, Besivance, Erythromycin, Protonix, Ranitidine, Nexium and Omeprazole and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 17:45 approximately 37 minutes after vaccination, the patient experienced an itchy throat and itching in the inside of her ears inside her throat area. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Itchy throat and itching in the inside of ears was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Rash was itchy; Hives; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 08Apr2021 at 00:00 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included bee sting hypersensitivity. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 12:00, the patient experienced hives and rash was itchy. The patient received first vaccine from Pfizer and was completely fine. Arm did not hurt and did not feel sick at all. After second dose, felt fine as well. Until two days after got this rash/hives that would flare up. It's extremely itchy and can only guess it's from the vaccine because routine had not changed. It hives/rash comes and goes but was extremely uncomfortable and was not sure when it will cease. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives and rash was itchy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nausea, Pregnancy test
Clinical narrative: feeling nausea from morning to night; uneasy feeling is persistent enough to hinder myotherwise active lifestyle.; This is a spontaneous report from a contactable other healthcare professional. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1283) via an unspecified route of administration in the arm left on 09Jan2021(at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included protein s deficiency and allergic to eggs. Concomitant medication included Intrauterine contraceptive device (MANUFACTURER UNKNOWN) from an unknown date for  birth control. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EJ11085) via intramuscular route of administration in the left arm on 19Dec2020 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Feb2021 at 10:00, the patient experienced nausea and uneasy feeling. It was reported that about a month after the second dose, the patient had been feeling nausea from morning to night. The patient  was not sure when exactly it began, but it was been consistent for the last few months. The patient had been made no changes to her life or diet and was tested negative for countless pregnancy tests, even one performed by doctor. The nausea was not strong enough to cause vomiting, but the uneasy feeling was persistent enough to hinder her otherwise active lifestyle. The patient had no doubts or fears for the safety of the vaccine, but she really hoped to hear back about whether this was a commonly reported occurrence or not. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On an unknown date, the patient underwent pregnancy test and the result was negative. The clinical outcome of the event nausea and uneasy feeling was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Fatigue, Influenza like illness, Pain
Clinical narrative: worsening of symptoms, flu like; worsening of symptoms, flu like; chills; fever; tired; achy; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, chronic obstructive pulmonary disease (COPD), hypothyroid and known allergy to penicillin. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT), tiotropium bromide monohydrate (SPIRIVA), levothyroxine sodium (SYNTHROID), losartan (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date. The patient previously took prednisone (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 10:00 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced chills, fever, tired and achy. On 06Apr2021, in evening, the patient experienced worsening of symptoms, flu like and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, tired and achy, worsening of symptoms, flu like symptoms were recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: worsening of symptoms, flu like; worsening of symptoms, flu like; chills; fever; tired; achy; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, chronic obstructive pulmonary disease (COPD), hypothyroid and known allergy to penicillin. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT), tiotropium bromide monohydrate (SPIRIVA), levothyroxine sodium (SYNTHROID), losartan (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date. The patient previously took prednisone (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 10:00 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced chills, fever, tired and achy. On 06Apr2021, in evening, the patient experienced worsening of symptoms, flu like and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, tired and achy, worsening of symptoms, flu like symptoms were recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: Face began to swell; Developed a rash; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 08:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy and asthma. The patient previously took  Augmentin and Pediazol and experienced drug allergy. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 08:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 09:00, within an hour of receiving the second dose, the patient face began to swell and developed a rash. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event face began to swell was resolved (within 48 hours) on 11Apr2021 and developed a rash was resolved (within 120 hours) on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Chills, Dizziness, Headache
Clinical narrative: Extremely sick-feeling; Chills; Sweats; Severe headache; Body ache; Wweakness; Dizziness; Nausea; Terrible nightmares; Sleep off and on; emotional feelings of dread and anxiety; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine with aura. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), lorazepam (ATIVAN), gabapentin (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 18Mar2021 at 11:40 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 02:00, the patient experienced extremely sick-feeling side effects; including chills, sweats, severe headache, body ache, weakness, dizziness, nausea. she could only lie in bed, drink water, and sleep off and on. At 2:00 pm, the patient took one TYLENOL and went back to sleep. At 5:00 pm it lifted, and she was able to act normally. She also experienced terrible nightmares, and it took several days to shake the emotional feelings of dread and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling sick, chills, sweaty, headache, ache, weakness, dizziness, nausea and poor sleep was recovered on 09Apr2021 at 17:00. The clinical outcome of the events lack of feeling emotions and nightmares was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Nausea, Nightmare, Pain
Clinical narrative: Extremely sick-feeling; Chills; Sweats; Severe headache; Body ache; Wweakness; Dizziness; Nausea; Terrible nightmares; Sleep off and on; emotional feelings of dread and anxiety; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine with aura. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), lorazepam (ATIVAN), gabapentin (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 18Mar2021 at 11:40 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 02:00, the patient experienced extremely sick-feeling side effects; including chills, sweats, severe headache, body ache, weakness, dizziness, nausea. she could only lie in bed, drink water, and sleep off and on. At 2:00 pm, the patient took one TYLENOL and went back to sleep. At 5:00 pm it lifted, and she was able to act normally. She also experienced terrible nightmares, and it took several days to shake the emotional feelings of dread and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling sick, chills, sweaty, headache, ache, weakness, dizziness, nausea and poor sleep was recovered on 09Apr2021 at 17:00. The clinical outcome of the events lack of feeling emotions and nightmares was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality sleep
Clinical narrative: Extremely sick-feeling; Chills; Sweats; Severe headache; Body ache; Wweakness; Dizziness; Nausea; Terrible nightmares; Sleep off and on; emotional feelings of dread and anxiety; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine with aura. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), lorazepam (ATIVAN), gabapentin (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 18Mar2021 at 11:40 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 02:00, the patient experienced extremely sick-feeling side effects; including chills, sweats, severe headache, body ache, weakness, dizziness, nausea. she could only lie in bed, drink water, and sleep off and on. At 2:00 pm, the patient took one TYLENOL and went back to sleep. At 5:00 pm it lifted, and she was able to act normally. She also experienced terrible nightmares, and it took several days to shake the emotional feelings of dread and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling sick, chills, sweaty, headache, ache, weakness, dizziness, nausea and poor sleep was recovered on 09Apr2021 at 17:00. The clinical outcome of the events lack of feeling emotions and nightmares was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Grip strength decreased, Insomnia, Loss of personal independence in daily activities, Pain
Clinical narrative: couldn't do ADLs; throbbing pain; upper trunk weakness; couldn't sleep; loss of grip; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 31Mar2021 at the age of 64 years old (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient was not pregnant at time of vaccination. The patient previously had BNT162B2 on 10-MAR-2021 02:00 PM at the age of 64 years old dose 1 via unspecified route in the left arm for COVID-19 immunisation. Medical history included penicillin allergy, allergies to sulfa drugs and food allergy from an unknown date. Concomitant medications included levothyroxine sodium, losartan, fluticasone propionate, salmeterol xinafoate (ADVAIR HFA), fluticasone, salmeterol (SERETAIDE DISKUS) and hydrochlorothiazide, telmisartan (PRITOR HCT); all taken for an unspecified indication, start and stop date were not reported. The patient previously took Ceclor. The patient experienced throbbing pain, unrelenting, upper trunk weakness, couldn't sleep due to pain and weakness, loss of grip, couldn't do ADLs on 02Apr2021 04:00 AM then went to PCP and was given Toradol shot IM, 6-day Medrol Dosepak,ref Neuro as treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The patient has not been COVID-9 tested since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The facility where the most recent COVID-19 vaccine was administered was in the hospital. he patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Fatigue, Food allergy, Headache, Illness
Clinical narrative: Allergic reaction to seafood, certain drinks, and certain food; Sick; Tiresome/fatigue; Headache; This is a spontaneous report from a contactable consumer (patient) via COVAES. This non-pregnant 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number 1424) via an unspecified route of administration in the right arm on 05Mar2021 (at 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received morphine from an unknown date for an unknown indication and experienced allergy. Prior to vaccination the patient had not been diagnosed with COVID-19 and had not received any other vaccines in the four weeks prior to the COVID vaccine. On 24Mar2021 the patient was sick for 6 days with tiresome/fatigue and headaches. She reported developing an allergic reaction to seafood, certain drinks and certain foods. She saw an allergist and was waiting on the results from an allergy test. She reported going to the emergency room twice and was treated with intravenous diphenhydramine hydrochloride (BENADRYL) and intravenous steroids. The patient received the second dose of BNT162B2 (lot number 0943) on 26Mar2021. The clinical outcomes of the events were not recovered. Since vaccination the patient had not been tested for COVID.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Laryngitis
Clinical narrative: Laryngitis; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the left arm on 05Apr2021 at 08:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included nebivolol hydrochloride (BYSTOLIC) from an unknown date for an unknown indication and unknown if ongoing. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG207) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021, the patient experienced laryngitis. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event laryngitis was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: Fever (99.9 Fahrenheit); Backache; Headache; Very fatigued; This is a spontaneous report from a contactable consumer. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 10Apr2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced fever (99.9 Fahrenheit), backache, headache and very fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether the therapeutic measures were taken as a result of the events. On 13Apr2021, the patient underwent temperature test and the result was 99.9 Fahrenheit. The clinical outcome of the events fever (99.9 Fahrenheit), backache, headache and very fatigued was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: within a few minutes had a numb feeling around her chin/the numbness was on the area between the chin and the nose, lower face, not inside the mouth; Slight soreness on the arm; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in right arm on 07Mar2021 16:50 (at the age of 67-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included arthritis from Jul2020 and ongoing. Patient had no family medical history relevant to adverse event. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN) taken from in Jul2020 and ongoing. Patient did not aadminister additional vaccines on same date of the Pfizer suspect. Patient did not receive other vaccine in four week. After first dose within in a few minutes on 07Mar2021 at 17:00, patient had numb feeling, between the chin and the nose, not inside the mouth, lower face. Patient stated it sort of felt like the local anesthetic used for dental work and that the numbness lasted about an hour. The next couple of days, after the vaccine in Mar2021, she had slight soreness on the arm. The events did not result in doctor or physician office visit and emergency room. She asked if this is considered a severe reaction. She asked if it is safe for her to take the second dose. She asked for clarification on what was meant by "severe allergic reaction (e.g. anaphylaxis)". She stated 3 weeks after the first dose was a holiday and they tried to reschedule it for the first week in April, at 4 weeks, but they said no one is making appointments at this time. They said they would call for another appointment. They called her husband and he got his second dose but they have not called her and it has now been 5 and a half weeks after the first dose and she still has no appointment. She asked if the recommendation is to wait 4 weeks. The caller asked what is the recommendation on how long to wait between getting another vaccine and getting this vaccine. What happens if it goes past 6 weeks for the second dose. Caller asked what would happen if you just receive one dose. The caller asked if you have to get the second dose at the same place as you get the first dose? She asked if the vaccine would be the same at both places? CVS told her she had to get the second dose at the same place she got her first dose. Response explained that there are no recommendations from Pfizer stating that you would have to get both doses of the vaccine at the same location but that this would be up to the vaccination provider. Caller asked has Pfizer heard of other reports like this. Outcome of the event numbness in face was resolved on 07Mar2021 and soreness on the arm was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site discolouration
Clinical narrative: Yellow color around the area of injection for 11 days now.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 13:45(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included no spleen and allergic to wasp. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 13:45(at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 13:45, the patient experienced yellow color around the area of injection for 11 days now. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event yellow color around the area of injection was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Skin warm, Urticaria
Clinical narrative: Large red welt (3-inch diameter) on arm that was hot to the touch; Large red welt (3" diameter) on arm; Abnormal exhaustion; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included allopurinol (ELAVIL) from unknown date taken for an unknown indication. The patient previously took zithromax (MANUFACTURER UNKNOWN) and compazine (MANUFACTURER UNKNOWN) for unknown indications and on unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 13:00, the patient experienced abnormal exhaustion, diarrhea and large red welt (3-inch diameter) on arm that was hot to the touch, all for the next 03 days after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the events abnormal exhaustion, diarrhea, large red welt (3-inch diameter) on arm and large red welt (3-inch diameter) on arm that was hot to the touch was resolved on 12Apr2021 (experienced events for the next 03 days after vaccination).   No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Temperature difference of extremities
Clinical narrative: Numbness and tingling throughout entire left arm; Tingling throughout entire left arm; Noticeable temperature drop in left arm; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 13Apr2021 at 06:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient did not have any allergies to medications, food, or other products. Concomitant medications included dexmethylphenidate (MANUFATURER UNKNOWN) since an unknown date for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 06:15, the patient experienced numbness and tingling throughout entire left arm and a noticeable temperature drop in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events numbness, tingling and temperature difference in arms was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Small rash on BCG scar next to vaccine injection site. Rashes on little finger of right hand, Rash on inner upper right arm, small rash on inner right thigh. Mild rash and itchiness on both facial cheeks. Rashes on genitalia.; Mild rash and itchiness on both facial cheeks.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included lymes disease on an unknown date in 2003 and gluten sensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 12:00, the patient experienced "small rash on BCG scar next to vaccine injection site. Rashes on little finger of right hand, Rash on inner upper right arm, small rash on inner right thigh. Mild rash and itchiness on both facial cheeks. Rashes on genitalia". The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of widespread rash and itchy rash  was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Terrible pain in both the forearm after 13 days post first dose of vaccine; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021 at 17:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as not applicable. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Apr2021, the patient experienced pain in both the forearms after 13 days post first dose of vaccine. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event terrible pain in both the forearms was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: Bilateral Breast Pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 02Apr2021 at 14:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and asthma. The patient had known allergies to Depoprovera. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 13:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced bilateral breast pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bilateral breast pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Nausea
Clinical narrative: Nausea; Chills; Sweating; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 07Apr2021 at 08:45 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included graves, sjogren's, gluten intolerance and suspected ankylosing spondylitis. Concomitant medications included levothyroxine sodium (SYNTHROID), linaclotide (LINZESS), cevimeline hydrochloride (EVOXAC), cod-liver oil (FISH OIL) and vitamins; all from unknown dates for unspecified indications.  The patient previously took sulfamethoxazole; trimethoprim (BACTRIM) on unknown date for an unspecified indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 17Mar2021 at 08:45 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 09:00, the patient experienced nausea, chills and sweating. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, chills and sweating were resolved on 13Apr2021 morning.    No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity
Clinical narrative: Sore arm; Body aches; Headache; This is a spontaneous report from a non-contactable consumer. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included mild walnut allergy. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 20:00, the patient experienced sore arm, body aches and headache. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm, body aches and headache were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Nasopharyngitis, Pyrexia, SARS-CoV-2 test
Clinical narrative: Chills; Fever; Bad cough/ worse cough; Bad cold; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04Apr2021 at 12:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took Codeine and experienced drug allergy. The patient did not receive other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:00, the patient experienced chills with fever, bad cold and bad cough. The patient reported that she got the vaccine on Sunday and on Tuesday night, she got chills with fever, got a bad cough, bad cold and further clarified that she still has a worse cough at the time of reporting. It was unknown whether any therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. On 10Apr2021, the patient underwent SARS-CoV-2 test(nasal swab) and the result was negative. The clinical outcome of the events chills, fever, bad cough and bad cold were not resolved at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Chills, Decreased appetite, Fatigue
Clinical narrative: Fever; chills; shaking; cold; sweating; no appetite; exhaustion; sore throat; lung pain; burning sensation; shooting pain; nightmares; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications included paracetamol (TYLENOL) for an unknown indication from an unknown date. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 17:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 11:00, the patient experienced fever 102.5 (unspecified units), chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events fever 102.5, chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares was recovered in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nasopharyngitis, Nightmare, Oropharyngeal pain, Pain
Clinical narrative: Fever; chills; shaking; cold; sweating; no appetite; exhaustion; sore throat; lung pain; burning sensation; shooting pain; nightmares; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications included paracetamol (TYLENOL) for an unknown indication from an unknown date. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 17:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 11:00, the patient experienced fever 102.5 (unspecified units), chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events fever 102.5, chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares was recovered in 2021.   No follow-up attempts are needed. No further information is expected.